With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Of the first patient in the US to receive treatment for a genetic disorder with the aid of CRISPR. Since it was sickled cells and not embryos that were modified, it went over pretty well. | Stein, NPR 2019